Lost to Follow-Up: Complications of an Invasive Giant Prolactinoma.
infarction
pituitary adenoma
prolactinoma
proptosis
vasospasm
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
15 Aug 2020
15 Aug 2020
Historique:
entrez:
18
9
2020
pubmed:
19
9
2020
medline:
19
9
2020
Statut:
epublish
Résumé
Invasive giant prolactinomas are a rare type of prolactin-secreting tumors. Most lactotroph adenomas, including giant prolactinomas, consist of the sparsely granulated subtype and respond well to medical therapy with dopamine agonists. Proptosis due to intra-orbital tumor extension and ischemic infarction are two rare complications associated with these tumors. We report a case of a 51-year-old woman with a 30-year history of a macroprolactinoma who was lost to follow-up and returned with severe proptosis, a 10-cm invasive sellar mass on imaging, and markedly elevated serum prolactin levels, consistent with invasive giant prolactinoma. She was initially managed with dopamine agonists followed by palliative debulking of the tumor, which microscopically demonstrated a highly proliferative neoplasm predominantly consisting of sparsely granulated lactotroph adenoma with a minor component of the rare and aggressive acidophil stem cell adenoma subtype. Postoperatively, she developed a large left middle cerebral artery infarct and ultimately died. This case is notable in that it demonstrates the aggressive nature of invasive giant prolactinomas when not treated and highlights two rare findings in patients with this tumor: orbital invasion and ischemic infarct.
Identifiants
pubmed: 32944476
doi: 10.7759/cureus.9763
pmc: PMC7489779
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e9763Informations de copyright
Copyright © 2020, Blackmon et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Surg Neurol Int. 2019 Jun 07;10:92
pubmed: 31528430
Pituitary. 2015 Jun;18(3):352-8
pubmed: 24965694
Endocr Rev. 2006 Aug;27(5):485-534
pubmed: 16705142
Childs Nerv Syst. 2020 Apr;36(4):853-856
pubmed: 31853893
J Neurol Surg A Cent Eur Neurosurg. 2013 Dec;74 Suppl 1:e119-23
pubmed: 24014099
No Shinkei Geka. 2002 Jun;30(6):623-8
pubmed: 12094689
Ophthalmic Plast Reconstr Surg. 2018 Nov/Dec;34(6):e196-e197
pubmed: 30320714
Brain Pathol. 2012 Jul;22(4):443-53
pubmed: 22697380
Eye (Lond). 2003 Nov;17(9):1032-4
pubmed: 14704754
Surg Neurol. 1983 Nov;20(5):391-5
pubmed: 6635929
J Clin Neurosci. 2014 Apr;21(4):541-6
pubmed: 24211140
Eur J Endocrinol. 2014 Jun;170(6):R213-27
pubmed: 24536090
Neurosurgery. 2012 Sep;71(1 Suppl Operative):173-80; discussion 180-1
pubmed: 22249952
Br J Radiol. 2008 Nov;81(971):e259-62
pubmed: 18941037
Future Oncol. 2012 Dec;8(12):1621-6
pubmed: 23231524
World Neurosurg. 2016 Aug;92:7-14
pubmed: 27155378
Ophthalmic Plast Reconstr Surg. 2002 Jan;18(1):64-71
pubmed: 11910327
Arch Argent Pediatr. 2018 Apr 1;116(2):e325-e330
pubmed: 29557627
World Neurosurg. 2018 Jan;109:233-241
pubmed: 28989047
J Fr Ophtalmol. 2009 Feb;32(2):133.e1-3
pubmed: 20579476